{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:52:47Z","timestamp":1761929567626,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":1456,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jmii.2011.09.018","type":"journal-article","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T07:45:54Z","timestamp":1323503154000},"page":"52-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections"],"prefix":"10.1016","volume":"45","author":[{"given":"Chung-Chih","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hsin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Wang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chwen-Je","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Uen","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ye","family":"Pong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2011.09.018_bib1","first-page":"470","article-title":"Data summary from January 1992 through June 2004","volume":"32","author":"National nosocomial infections surveillance (NNIS) system report","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jmii.2011.09.018_bib2","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/313440","article-title":"Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms","volume":"29","author":"Gonz\u00e1lez","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/314712","article-title":"Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients","volume":"179","author":"Fowler","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib4","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2011.09.018_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0196-4399(02)80007-1","article-title":"Daptomycin: a novel lipopeptide antibiotic","volume":"24","author":"Thorne","year":"2002","journal-title":"Clin Microbiol News"},{"year":"2003","series-title":"Cubicin (daptomycin for injection) product information","author":"Cubist Pharmaceuticals","key":"10.1016\/j.jmii.2011.09.018_bib6"},{"key":"10.1016\/j.jmii.2011.09.018_bib7","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2011.09.018_bib9","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jac\/dkn372","article-title":"Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates","volume":"62","author":"Rehm","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1179\/joc.2009.21.4.414","article-title":"Safety and efficacy of daptomycin in the treatment of osteomyelitis: results from the CORE registry","volume":"21","author":"Crompton","year":"2009","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib11","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1345\/aph.1M085","article-title":"Safety and clinical outcomes when utilizing high-dose (> or =8\u00a0mg\/kg) daptomycin therapy","volume":"43","author":"Moise","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmii.2011.09.018_bib12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.surg.2009.03.037","article-title":"Daptomycin for the treatment of surgical site infections","volume":"146","author":"Chamberlain","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.jmii.2011.09.018_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/600039","article-title":"Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program","volume":"49","author":"Figueroa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib14","unstructured":"Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A7, 7th ed. Wayne, PA: CLSI 2009."},{"key":"10.1016\/j.jmii.2011.09.018_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0732-8893(00)00164-4","article-title":"Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in\u00a0vitro tests","volume":"38","author":"Fuchs","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2011.09.018_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00776-005-0968-7","article-title":"Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases","volume":"11","author":"Nishimura","year":"2006","journal-title":"J Orthop Sci"},{"key":"10.1016\/j.jmii.2011.09.018_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/AAC.00576-06","article-title":"High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm","volume":"51","author":"Weigel","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/AAC.36.2.318","article-title":"Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers","volume":"36","author":"Woodworth","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In\u00a0vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib21","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1128\/AAC.00102-08","article-title":"Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in\u00a0vitro pharmacodynamic model with simulated endocardial vegetations","volume":"52","author":"Rose","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jac\/46.4.523","article-title":"Development of daptomycin for Gram-positive infections","volume":"46","author":"Tally","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1592\/phco.26.3.347","article-title":"Daptomycin for the treatment of Gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients","volume":"26","author":"Segreti","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jmii.2011.09.018_bib24","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1128\/JCM.43.10.5384-5387.2005","article-title":"Clinical progression of methicillin resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin","volume":"43","author":"Vikram","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2011.09.018_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/JCM.44.2.595-597.2006","article-title":"Emergence of a clinical daptomycin resistant Staphylococcus aureus isolate during treatment of methicillin resistant Staphylococcus aureus bacteremia and osteomyelitis","volume":"44","author":"Marty","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2011.09.018_bib26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.50.4.1581-1585.2006","article-title":"Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin","volume":"50","author":"Sakoulas","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/JCM.01844-07","article-title":"Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan","volume":"46","author":"Huang","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2011.09.018_bib29","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/591280","article-title":"Fatal bacteremic mycotic aneurysm complicated by acute renal failure caused by Daptomycin-nonsusceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus","volume":"47","author":"Kuo","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijantimicag.2008.06.028","article-title":"Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus in a patient with chronic kidney disease","volume":"33","author":"Kuo","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2011.09.018_bib31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijantimicag.2008.07.004","article-title":"Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by methicillin-resistant Staphylococcus aureus","volume":"32","author":"Liu","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2011.09.018_bib32","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/513203","article-title":"The rationale for revising the clinical and laboratory standards institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus","volume":"44","author":"Tenover","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib33","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/AAC.00678-06","article-title":"Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) isolates","volume":"50","author":"Wootton","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.09.018_bib34","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1086\/507109","article-title":"The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin","volume":"43","author":"Sader","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.diagmicrobio.2005.07.001","article-title":"Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003)","volume":"53","author":"Sader","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2011.09.018_bib36","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2006.10.007","article-title":"Evaluation of the in\u00a0vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002\u20132005)","volume":"57","author":"Pfaller","year":"2007","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211001733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211001733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:16:16Z","timestamp":1761657376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118211001733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1684118211001733"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2011.09.018","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2011.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}